APA (7th ed.) Citation

Goerg, A., Piendl, G., Albert, V., Ortmann, O., Wege, A. K., & Brockhoff, G. Mdm2 targeting via PROteolysis TArgeting Chimeras (PROTAC) is efficient in p53 wildtype, p53-mutated, and abemaciclib-resistant estrogen receptor-positive cell lines and superior to mdm2 inhibition. BMC.

Chicago Style (17th ed.) Citation

Goerg, Alina, Gerhard Piendl, Veruschka Albert, Olaf Ortmann, Anja Kathrin Wege, and Gero Brockhoff. Mdm2 Targeting via PROteolysis TArgeting Chimeras (PROTAC) Is Efficient in P53 Wildtype, P53-mutated, and Abemaciclib-resistant Estrogen Receptor-positive Cell Lines and Superior to Mdm2 Inhibition. BMC.

MLA (9th ed.) Citation

Goerg, Alina, et al. Mdm2 Targeting via PROteolysis TArgeting Chimeras (PROTAC) Is Efficient in P53 Wildtype, P53-mutated, and Abemaciclib-resistant Estrogen Receptor-positive Cell Lines and Superior to Mdm2 Inhibition. BMC.